Latest Strategic Partnerships News

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Temas Resources has appointed Nic Matich as a Non-Executive Director to spearhead Australian investor relations and business development, while CFO David Robinson transitions to a full-time executive role to sharpen financial oversight amid the company’s growth and commercialisation push.

Carnaby Resources has announced a significant update to its Greater Duchess Copper Gold Project, reporting a 10% increase in total mineral resources and a 49% rise in indicated resources. With the Pre-Feasibility Study nearing completion and binding agreements in place, the company targets first ore production in the second half of 2026.

Mont Royal Resources has signed a non-binding Memorandum of Understanding with the Saguenay Port Authority to explore locating a hydrometallurgical facility for its Ashram Rare Earths Project in Québec, leveraging the port’s strategic logistics and industrial infrastructure.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Ragusa Minerals has significantly expanded its Purple Pansy Manganese-Gold Project in Arizona by acquiring 201 additional tenements, enhancing its strategic landholding and exploration potential in a critical minerals hotspot.

Control Bionics has partnered with Tobii Dynavox to pilot its NeuroNode technology across five US states, aiming to enhance communication access for users of augmentative devices.

Canadian Phosphate Limited has improved its operating cash flow and strengthened its balance sheet through a successful capital raise and asset sale, while advancing key permits and strategic partnerships for its Canadian phosphate projects.

Ioneer Ltd has reported a significant uplift in the economics of its Rhyolite Ridge lithium-boron project, alongside ongoing strategic partnership talks and strong market demand for lithium and boric acid.

Cycliq Group Ltd reported a 21% decline in customer receipts for Q2 FY2026, offset by a solid net operating cash inflow and a strong Black Friday campaign that generated $1.3 million in gross revenue.

Parabellum Resources has completed Phase 3 drilling at its Miandetta prospect, confirming continuous near-surface nickel and cobalt mineralisation. The company is advancing exploration while actively seeking new precious and base metal projects.

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.